Teligent Canada

Teligent Canada is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of generic prescription medicines. The company specializes in complex dosage forms, including topical creams, ointments, gels, and injectable formulations. Its product portfolio serves both the retail pharmacy and hospital sectors across Canada, with a strong emphasis on dermatology and critical care. Originally operating as the Canadian subsidiary of the New Jersey-based Teligent, Inc., the company built a robust pipeline of Abbreviated New Drug Submissions (ANDS). In early 2022, following the financial restructuring of its parent organization, Teligent Canada was acquired by Pendu Pharma.